![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Department of Pharmacology (D.F., S.G., D.P.) and Center for the Neurobiology of Learning and Memory (D.P.), University of California, Irvine, California, Istituto di Chimica Farmaceutica e Tossicologica, Università degli Studi di Urbino Carlo Bo, Urbino, Italy (A.D., A.T.G.T.); and Dipartimento Farmaceutico, Università degli Studi di Parma, Parma, Italy (M.M.)
Fatty acid amide hydrolase (FAAH) is an intracellular serine enzyme that catalyzes the hydrolysis of bioactive fatty acid ethanolamides such as anandamide and oleoylethanolamide (OEA). Genetic deletion of the faah gene in mice elevates brain anandamide levels and amplifies the effects of this endogenous cannabinoid agonist. Here, we show that systemic administration of the selective FAAH inhibitor URB597 (cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester; 0.3 mg/kg i.p.) increases anandamide levels in the brain of rats and wild-type mice but has no such effect in FAAH-null mutants. Moreover, URB597 enhances the hypothermic actions of anandamide (5 mg/kg i.p.) in wild-type mice but not in FAAH-null mice. In contrast, the FAAH inhibitor does not affect anandamide or OEA levels in the rat duodenum at doses that completely inhibit FAAH activity. In addition, URB597 does not alter the hypophagic response elicited by OEA (5 and 10 mg/kg i.p.), which is mediated by activation of peroxisome proliferator-activated receptor type-
. Finally, exogenously administered OEA (5 mg/kg i.p.) was eliminated at comparable rates in wild-type and FAAH-/- mice. Our results indicate that URB597 increases brain anandamide levels and magnifies anandamide responses by inhibiting intracellular FAAH activity. The results also suggest that an enzyme distinct from FAAH catalyzes OEA hydrolysis in the duodenum, where this lipid substance acts as a local satiety factor.
Address correspondence to: Dr. Daniele Piomelli, Department of Pharmacology, 3101 Gillespie NRF, University of California, Irvine CA 92697-4625. E-mail: piomelli{at}uci.edu
This article has been cited by other articles:
|
|
 |
|
  L. M. Lauffer, R. Iakoubov, and P. L. Brubaker GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell Diabetes, May 1, 2009; 58(5): 1058 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mazzola, J. Medalie, M. Scherma, L. V. Panlilio, M. Solinas, G. Tanda, F. Drago, J. L. Cadet, S. R. Goldberg, and S. Yasar Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-{alpha} nuclear receptors Learn. Mem., April 29, 2009; 16(5): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Schlosburg, D. L. Boger, B. F. Cravatt, and A. H. Lichtman Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 314 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Lever, M. Robinson, M. Cibelli, C. Paule, P. Santha, L. Yee, S. P. Hunt, B. F. Cravatt, M. R. Elphick, I. Nagy, et al. Localization of the Endocannabinoid-Degrading Enzyme Fatty Acid Amide Hydrolase in Rat Dorsal Root Ganglion Cells and Its Regulation after Peripheral Nerve Injury J. Neurosci., March 25, 2009; 29(12): 3766 - 3780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Karbarz, L. Luo, L. Chang, C.-S. Tham, J. A. Palmer, S. J. Wilson, M. L. Wennerholm, S. M. Brown, B. P. Scott, R. L. Apodaca, et al. Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase Anesth. Analg., January 1, 2009; 108(1): 316 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Melis, G. Pillolla, A. Luchicchi, A. L. Muntoni, S. Yasar, S. R. Goldberg, and M. Pistis Endogenous Fatty Acid Ethanolamides Suppress Nicotine-Induced Activation of Mesolimbic Dopamine Neurons through Nuclear Receptors J. Neurosci., December 17, 2008; 28(51): 13985 - 13994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Scherma, L. V. Panlilio, P. Fadda, L. Fattore, I. Gamaleddin, B. Le Foll, Z. Justinova, E. Mikics, J. Haller, J. Medalie, et al. Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3'-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 482 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Khasabova, S. G. Khasabov, C. Harding-Rose, L. G. Coicou, B. A. Seybold, A. E. Lindberg, C. D. Steevens, D. A. Simone, and V. S. Seybold A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia in a Model of Bone Cancer Pain J. Neurosci., October 29, 2008; 28(44): 11141 - 11152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Merritt, B. R. Martin, C. Walters, A. H. Lichtman, and M. I. Damaj The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Russo, J. LoVerme, G. La Rana, T. R. Compton, J. Parrott, A. Duranti, A. Tontini, M. Mor, G. Tarzia, A. Calignano, et al. The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3'-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 236 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Solinas, G. Tanda, Z. Justinova, C. E. Wertheim, S. Yasar, D. Piomelli, S. K. Vadivel, A. Makriyannis, and S. R. Goldberg The Endogenous Cannabinoid Anandamide Produces {delta}-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 370 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Muccioli, C. Xu, E. Odah, E. Cudaback, J. A. Cisneros, D. M. Lambert, M. L. Lopez Rodriguez, S. Bajjalieh, and N. Stella Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells J. Neurosci., March 14, 2007; 27(11): 2883 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Jhaveri, D. Richardson, D. A. Kendall, D. A. Barrett, and V. Chapman Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain J. Neurosci., December 20, 2006; 26(51): 13318 - 13327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, F. Ramirez, G. Krishnamurthy, A. Gilbert, N. Kadakia, J. Xu, G. Kalgaonkar, M. K. Ramarao, W. Edris, K. E. Rogers, et al. High-Throughput Screening for the Discovery of Inhibitors of Fatty Acid Amide Hydrolase Using a Microsome-Based Fluorescent Assay J Biomol Screen, August 1, 2006; 11(5): 519 - 527. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Astarita, B. C. Rourke, J. B. Andersen, J. Fu, J. H. Kim, A. F. Bennett, J. W. Hicks, and D. Piomelli Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus) Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1407 - R1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gobbi, F. R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo, M. Solinas, T. Cassano, M. G. Morgese, G. Debonnel, A. Duranti, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis PNAS, December 20, 2005; 102(51): 18620 - 18625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mechoulam and D. G. Deutsch Toward an anandamide transporter PNAS, December 6, 2005; 102(49): 17541 - 17542. [Full Text] [PDF]
|
|
|
|
 |
|
 K.-M. Jung, R. Mangieri, C. Stapleton, J. Kim, D. Fegley, M. Wallace, K. Mackie, and D. Piomelli Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors Mol. Pharmacol., November 1, 2005; 68(5): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Van Sickle, M. Duncan, P. J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J. S. Davison, et al. Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors Science, October 14, 2005; 310(5746): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
